Healthcare Capital Acquisition Corp. (NASDAQ:HCAC – Get Free Report) saw a significant decline in short interest in August. As of August 31st, there was short interest totaling 2,153 shares, a decline of 54.3% from the August 15th total of 4,707 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 46,203 shares, the short-interest ratio is presently 0.0 days.
Healthcare Capital Acquisition Stock Performance
Shares of HCAC opened at $10.10 on Monday. Healthcare Capital Acquisition has a 12 month low of $9.91 and a 12 month high of $10.11. The firm has a fifty day simple moving average of $10.08 and a 200 day simple moving average of $10.02. The stock has a market capitalization of $376.80 million, a price-to-earnings ratio of 202.00 and a beta of 0.41.
Institutional Trading of Healthcare Capital Acquisition
A hedge fund recently bought a new position in Healthcare Capital Acquisition stock. BlueCrest Capital Management Ltd purchased a new stake in shares of Healthcare Capital Acquisition Corp. (NASDAQ:HCAC – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 250,000 shares of the company’s stock, valued at approximately $2,510,000. BlueCrest Capital Management Ltd owned about 0.67% of Healthcare Capital Acquisition as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 66.82% of the company’s stock.
Analyst Upgrades and Downgrades
Get Our Latest Analysis on Healthcare Capital Acquisition
About Healthcare Capital Acquisition
Healthcare Capital Acquisition Corp. (NASDAQ: HCAC) was a special purpose acquisition company (SPAC) formed to pursue a business combination with a company in the healthcare industry. As a blank-check company, it did not operate a healthcare business or offer its own products and services.
Its investment focus was broadly oriented toward healthcare, life sciences, medical technology, pharmaceuticals, biotechnology, diagnostics and related sectors. The company’s principal activity was identifying a suitable target, negotiating a transaction and obtaining approval from its shareholders and other stakeholders.
Because Healthcare Capital Acquisition Corp.
Recommended Stories
- Five stocks we like better than Healthcare Capital Acquisition
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits
Receive News & Ratings for Healthcare Capital Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Capital Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
